$TLRY

Tilray Brands to Report First Fiscal Quarter 2026 Financial Results on October 8

Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY) will release its first fiscal quarter 2026 financial results on October 8, 2026, before market open. The company will host a live conference call at 8:30 AM ET to discuss the results. Tilray operates in cannabis, beverage, wellness, and entertainment industries across multiple countries.

Original reporting
Published Sep 25, 2026, 1:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 25, 2026, 1:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Tilray Brands to Report First Fiscal Quarter 2026 Financial Results on October 8 — source image
Decision brief

The 30-second read

$TLRYNeutralLow
01

Why it matters

The press release sets the timeline for the upcoming earnings release but does not affect valuation today.

02

Market read

The announcement is primarily informational; traders will likely wait for the actual earnings release.

03

What to watch

Potential guidance hints or management commentary that could be hinted in the upcoming call.

Relevance 4/10Novelty 3/10Timing: announcement today

Background

Tilray Brands is a publicly traded cannabis and consumer goods company that operates globally.

Company-level read

Ticker impact

$TLRYNeutralHigh confidence
Context

Tilray Brands announced it will release its Q1 2026 financial results on October 8, 2026.

Expected impact

Minimal immediate price movement; any impact will depend on the actual results.

Evidence & confidence

No numbers or guidance were disclosed, so traders have no actionable information today.

Market effects

Cannabis sector may see modest attention ahead of the earnings date.

North American markets, especially U.S. and Canadian cannabis stocks.

Low

Counterpoint

Some traders may view the date announcement as a non-event and ignore it.

Key entities

  • Tilray Brands, Inc.

    Global cannabis and consumer packaged goods company.

Related articles

$TLRYLow

Should you sell your Tilray stock?

Tilray Brands (TSX:TLRY) reported fiscal Q1 2027 revenue of $257.1M and Adjusted EBITDA of $9.2M, missing analyst estimates. Cannabis revenue fell 13% year-over-year, while beverage alcohol revenue rose 82.1%. Analyst Neal Gilmer maintained a 'Hold' rating and $4.00 target, citing concerns about organic growth and cash flow.

$TLRYMed

Tilray Brands revenue rises 20% in Q1 2027

Tilray Brands reported a 20% revenue increase to $257.1M in Q1 2027, driven by beverage sales. Gross profit rose 35% to $77.5M. Beverage revenue grew 82% to $101.5M, while cannabis revenue declined. The company reported a net loss of $40M but reduced debt by $42M. Tilray reaffirmed its adjusted EBITDA guidance of $68M-$75M for the fiscal year.

$TLRYMedAI 8/10

Tilray (TLRY) Q1 2027 Earnings Call Transcript

Tilray (TLRY) reported Q1 2027 revenue of $257 million, up 23% YoY, with expanded gross margins. The company highlighted its global scale, leadership in cannabis, beverage, and wellness, and strategic acquisitions like BrewDog. Tilray emphasized its diversified business model, international growth, and cost reductions in key markets like Portugal and Germany.

$TLRYMedAI 8/10

Tilray Brands Inc (TLRY) (Q1 2027) Earnings Call Highlights: Record Revenue

Tilray Brands Inc (TLRY) reported a Q1 net loss of $40M, down from a $1.5M profit last year, due to higher marketing costs and fuel surcharges. Revenue was impacted by cannabis price compression, supply constraints, and inventory shifts. BrewDog turned profitable, and the company expects continued growth. Tilray also discussed partnerships, international expansion, and potential M&A opportunities.

$TLRYHigh

Tilray Brands swings to $40M loss as revenue rises

Tilray Brands reported a net loss of $40.0 million for Q2 2026, despite revenue growth to $257.1 million. Gross profit rose to $77.5 million, but operating loss was $24.1 million. Cannabis revenue declined, while beverage revenue increased. The company issued shares to repay debt and amended credit agreements to ease covenant testing.